Previous close | 2.6320 |
Open | 1.8560 |
Bid | 0.0000 x 200000 |
Ask | 0.0000 x 200000 |
Day's range | 1.7840 - 1.9700 |
52-week range | 0.9760 - 4.4020 |
Volume | |
Avg. volume | 732 |
Market cap | 125.15M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 13.14 |
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript May 8, 2024 CytomX Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.1669, expectations were $-0.03. CytomX Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
Q1 2024 CytomX Therapeutics Inc Earnings Call
Explore key financial outcomes and clinical advancements as CytomX Therapeutics Inc (CTMX) navigates through Q1 2024 with robust partnerships and innovative cancer treatments.